Dynatronics Corp (DYNT): Market Cap to Revenue

Symbol and logo of brand Dynatronics Corp. (DYNT)

Growth for Dynatronics Corporation (DYNT) is being constrained by reductions in government clinic budgets and fierce competition within the rehabilitation niche. The historical P/S ratio confirms valuation volatility, with the most recent value recorded as 0.00. Stability is supported by the implementation of energy-efficient production cycles and eco-friendly packaging; however, the complete abandonment of in-house R&D in favor of distribution nullifies the company's technological potential.

DYNT Dynatronics Corp. P/S Multiple (07/04/2022 - 08/04/2024)

Analytical breakdowns for Dynatronics Corporation (DYNT)

- share price and consensus valuation forecast:
Price Performance Chart dynatronics.com|DYNT - Price Target Chart
- stock exchange capitalization data:
Market Valuation Dynatronics Corp.|DYNT - Enterprise Value
- book value of equity indicators:
Net Asset Value per Share Dynatronics|DYNT - Book Capitalization|Capitalization to Book Value Ratio dynatronics.com|DYNT - Company Total Assets
- debt obligations and liquidity statistics:
Total Debt to Capital Coefficient Dynatronics Corporation|DYNT - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio dynatronics.com|DYNT - Company Aggregate Debts|Debts to Book Capitalization Dynatronics Corp.|DYNT - Company Long-Term Debt|Company Short-Term Debt Dynatronics|Intermediate Coverage Ratio dynatronics.com
- earnings and multiples data:
DYNT - Net Profit|Expected Net Profit Dynatronics Corporation|DYNT - Price to Earnings Ratio|Forward Price to Earnings Multiple dynatronics.com|DYNT - Price/Earnings to Growth Multiple|EV/EBITDA Multiple Dynatronics Corp.|DYNT - Operating profit EBITDA|Net earnings per share for the last four quarters Dynatronics|DYNT - Earnings per share for the last twelve months|Year-over-year net earnings per share trend for the last twelve months dynatronics.com|DYNT - Earnings per share growth in current year|Expected earnings per share growth for next year Dynatronics Corporation
- issuer revenue and sales details:
DYNT - Revenue and Sales Volume|Company Expected Sales Volume dynatronics.com|DYNT - Price-to-Revenue Ratio|Market Cap to Projected Revenue Dynatronics Corp.
General company analysis:DYNT Dynatronics Corp
Core merchandise of Dynatronics

The P/S ratio determines the market value of one dollar of revenue, allowing an investor to assess the extent of overpayment for a business relative to its sales volumes. When analyzing the market capitalization-to-revenue ratio of Dynatronics Corporation (DYNT), one must consider the company's limited pricing power in the rehabilitation sector, which makes this metric a key indicator of business resilience amid fierce competition and low margins.

Competitors of Dynatronics Corporation

BSX (bostonscientific.com) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Edwards Lifesciences Corporation EW|RMD - Market Cap to Revenue|OmniPod - P/S Multiple|Price to Sales Zimmer Biomet Holdings|COO: P/S Multiple|Market Cap to Revenue Ratio ALGN|GMED (Globus Medical) - P/S Multiple|TransMedics Group Inc (TMDX) - Price-to-Revenue Coefficient|P/S Multiple ATEC|Market Cap to Revenue Artivion Corp AORT|P/S Multiple ENOV (Enovis Corporation)|P/S Multiple integralife.com IART|ESTA - Price-to-Revenue Ratio|BBNX: Price-to-Revenue Ratio|IRMD (Iradimed) - Market Cap to Revenue|Embecta Health - Market Capitalization-to-Revenue Ratio|TNDM (Tandem Diabetes Care) - P/S Multiple|Price to Sales axogeninc.com AXGN|Price-to-Revenue Ratio SI-BONE (SIBN)|Orthofix Medical (OFIX) - Price-to-Revenue Multiple|Bioventus Corp - Market Cap to Revenue|P/S Multiple OrthoPediatrics Corp KIDS|Treace Medical Concepts - P/S Multiple|Price-to-Revenue Coefficient blade.com SRTA|Carlsmed (CARL) - Price-to-Revenue Ratio|Price-to-Sales Ratio RXST (RxSight Inc)|Price-to-Revenue Ratio ClearPoint Neuro Inc.|Market Cap to Revenue Stereotaxis Corporation (STXS)|P/S Multiple STIM|SGHT - Price to Sales|Price-to-Revenue Ratio Orchestra BioMed, Inc. OBIO|ANIK: Market Cap to Revenue Ratio|NSPR: Market Cap to Revenue|Jin Medical International - Market Cap to Sales Volume|VANI: P/S Multiple|Market Cap to Revenue Ratio XTNT|Market Cap to Revenue NMTC|Price to Sales Modular Med MODD|Price-to-Revenue Ratio Myomo, Inc (MYO)|Envoy Medical Inc - Market Cap to Revenue Ratio|P/S Multiple VVOS (Vivos Therapeutics)|P/S Multiple envveno.com NVNO|SINT: Market Cap to Revenue|Tenon Medical Inc. - Market Cap to Sales Volume|ReWalk Robotics Ltd (LFWD) - Price-to-Revenue Ratio|Autonomix Medical - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio INVO Fertility Inc|Price to Sales bonebiologics.com BBLG|Price-to-Revenue Ratio Axonics (AXNX)|BIOLASE Inc. - Market Cap to Revenue Ratio|P/S Multiple FNA (Paragon 28)|Price-to-Revenue Coefficient INVO Bioscience Inc. (INVO)